MOHAMAD A HUSSEIN
Medical Practice at Copeland Farms Rd, Odessa, FL
License number
Florida 98068
Issued Date
Mar 12, 2007
Effective Date
Jan 7, 2015
Expiration Date
Jan 31, 2019
Category
Health Care
Type
Medical Doctor
Address
Address
2
16107 Copeland Farms Rd, Odessa, FL 33556
12901 Bruce B Downs Blvd, Tampa, FL 33612
12901 Bruce B Downs Blvd, Tampa, FL 33612
Phone
(813) 641-1433
Personal information
See more information about MOHAMAD A HUSSEIN at radaris.comName
Address
Phone
1608 Long Ridge Ct, Orlando, FL 32807
16107 Copeland Farms Rd, Odessa, FL 33556
4580 Old Carriage Trl, Oviedo, FL 32765
1608 Long Ridge Ct #274, Orlando, FL 32807
3559 Idle Hour Dr, Orlando, FL 32822
Organization information
See more information about MOHAMAD A HUSSEIN at bizstanding.comMohamad A Hussein MD
12901 Bruce B Downs Blvd, Tampa, FL 33612
Industry:
Internist
Doing business as:
Mohamad Hussein MD
Phone:
(813) 974-2120 (Phone), (813) 974-2201 (Phone)
Mohamad Ahmed Hussein
Categories:
Physicians & Surgeons
Professional information
Mohamad A Hussein, Tampa FL
Specialties:
Oncologist
Address:
12901 Bruce B Downs Blvd, Tampa, FL 33612
N Florida Ave, Tampa, FL 33612
N Florida Ave, Tampa, FL 33612
Education:
Ain Shams University, Faculty of Medicine - Doctor of Medicine*
University of Maryland Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)*
Cleveland Clinic Hospital - Residency - Internal Medicine*
University of Mississippi Medical Center - Residency - Internal Medicine*
University of Maryland Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)*
Cleveland Clinic Hospital - Residency - Internal Medicine*
University of Mississippi Medical Center - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)*
Dr. Mohamad A Hussein, Tampa FL - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
University South Florida Physical Grp
12901 Bruce B Downs Blvd, Tampa 33612
(813) 974-2201 (Phone)
12902 Usf Magnolia Dr, Tampa 33612
(813) 972-4673 (Phone)
12901 Bruce B Downs Blvd, Tampa 33612
(813) 974-2201 (Phone)
12902 Usf Magnolia Dr, Tampa 33612
(813) 972-4673 (Phone)
Certifications:
Internal Medicine, 1986, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University South Florida Physical Grp
12901 Bruce B Downs Blvd, Tampa 33612
12902 Usf Magnolia Dr, Tampa 33612
Memorial Hospital of Tampa
2901 Swann Ave, Tampa 33609
Saint Joseph's Hospital
3001 West Dr Martin Luther King Jr Blvd, Tampa 33607
Tampa General Hospital
1 Tampa General Cir, Tampa 33606
12901 Bruce B Downs Blvd, Tampa 33612
12902 Usf Magnolia Dr, Tampa 33612
Memorial Hospital of Tampa
2901 Swann Ave, Tampa 33609
Saint Joseph's Hospital
3001 West Dr Martin Luther King Jr Blvd, Tampa 33607
Tampa General Hospital
1 Tampa General Cir, Tampa 33606
Education:
Medical School
Ain Shams University, Faculty Of Medicine
Graduated: 1981
Ein Shams University Hosps
Graduated: 1983
Cleveland Clinic Foundation
Graduated: 1986
University Miss Med Center
Graduated: 1985
University MD Canc Center
Graduated: 1989
Ain Shams University, Faculty Of Medicine
Graduated: 1981
Ein Shams University Hosps
Graduated: 1983
Cleveland Clinic Foundation
Graduated: 1986
University Miss Med Center
Graduated: 1985
University MD Canc Center
Graduated: 1989
Head Myeloma Section At Hl Moffitt
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Health, Wellness and Fitness
Methods And Materials For Monitoring Myeloma Using Quantitative Mass Spectrometry
US Patent:
2011015, Jun 23, 2011
Filed:
Jun 30, 2009
Appl. No.:
12/997210
Inventors:
John Matthew Koomen - Tampa FL, US
Elizabeth Renee Remily - Lutz FL, US
Kaaron Benson - Apollo Beach FL, US
Mohamad Hussein - Odessa FL, US
Elizabeth Renee Remily - Lutz FL, US
Kaaron Benson - Apollo Beach FL, US
Mohamad Hussein - Odessa FL, US
Assignee:
H. Lee Moffit Cancer & Research Institute - Tampa FL
International Classification:
C12Q 1/37, C07K 7/06, C07K 7/08, G01N 33/48
US Classification:
435 23, 530328, 530327, 530326, 436 86
Abstract:
The subject invention concerns methods and materials for diagnosing, monitoring the progress, and/or providing a prognosis for multiple myeloma and other conditions associated with antibody production in a person or animal. The methods o f the invention utilize mass spectrometry for quantitative monitoring and detection of antibody produced by the plasma cells. The methods of the invention can be utilized for diagnosis, monitoring, and/or prognosis of multiple myeloma, monoclonal gammopathy, and other immunological or hematological conditions and disorders. In addition to detecting and quantifying antibody in a sample, other biological markers, such as serum albumin and/or beta-2-microglobulin, can also be detected and quantified using the present invention, and in combination with detection and quantification of antibody. Thus, in one embodiment, both antibody and serum albumin and/or beta-2-microglobulin are detected and quantified using mass spectrometry and a diagnosis or prognosis made based on the results and levels detected.
Methods And Materials For Monitoring Myeloma Using Quantitative Mass Spectrometry
US Patent:
2013026, Oct 3, 2013
Filed:
May 30, 2013
Appl. No.:
13/905549
Inventors:
Elizabeth Renee Remily - Lutz FL, US
Kaaron Benson - Apollo Beach FL, US
Mohamad Hussein - Odessa FL, US
Kaaron Benson - Apollo Beach FL, US
Mohamad Hussein - Odessa FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
International Classification:
G01N 33/68
US Classification:
435 23
Abstract:
The subject invention concerns methods and materials for diagnosing, monitoring the progress, and/or providing a prognosis for multiple myeloma and other conditions associated with antibody production in a person or animal. The methods of the invention utilize mass spectrometry for quantitative monitoring and detection of antibody produced by the plasma cells. The methods of the invention can be utilized for diagnosis, monitoring, and/or prognosis of multiple myeloma, monoclonal gammopathy, and other immunological or hematological conditions and disorders. In addition to detecting and quantifying antibody in a sample, other biological markers, such as serum albumin and/or beta-2-microglobulin, can also be detected and quantified using the present invention, and in combination with detection and quantification of antibody. Thus, in one embodiment, both antibody and serum albumin and/or beta-2-microglobulin are detected and quantified using mass spectrometry and a diagnosis or prognosis made based on the results and levels detected.